Yolanda Arlette Santacruz

Dr. Yolanda Arlette Santacruz


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Foods
Verified
Journal Article
Open access
PDF file
PFPaulinna Faccinetto
Paulinna Faccinetto
Andrea Gómez-FernándezAndrea Gómez-Fernández
Andrea Gómez-Fernández
YSYolanda Arlette Santacruz
Yolanda Arlette Santacruz
Daniel Jacobo-VelázquezDaniel Jacobo-Velázquez
Daniel Jacobo-Velázquez
Consumer demand for healthier foods with improved taste and convenience has urged the food industry to develop functional foods added with bioactive ingredients that can supplement basic nutrition (food supplement) or exert a pharmacological effect (nutraceuticals). Chocolate could be used as an ideal carrier to deliver bioactive ingredients, mainly due to its high acceptability by consumers. However, a drawback of using chocolate as functional food is its high sugar content, which impedes its commercialization with the diabetic population. Therefore, there is need to develop sugar-free chocolate formulations added with bioactive ingredients. Nevertheless, sugar replacement and bioactive ingredients addition is a major technological challenge that affects texture, rheology, and sensory properties of chocolate. This review is designed as a practical guide for researchers and food industries to develop the next generation of functional chocolates. Different functional chocolate formulations, including sugar-free, are reviewed as potential carriers for the delivery of bioactive compounds. The physicochemical properties and sensory acceptability of the functional chocolates presented are also highlighted. Finally, future perspectives, such as the use of nanotechnology to improve the bioaccessibility and bioavailability of active ingredients, as well as the need for clinical trials to validate the pharmacological effect of functional chocolates, are also discussed.

4 February 2021 in Foods
Verified
Journal Article
Open access
PDF file
PFPaulinna Faccinetto
Paulinna Faccinetto
Andrea Gómez-FernándezAndrea Gómez-Fernández
Andrea Gómez-Fernández
NONorma E. Orozco-Sánchez
Norma E. Orozco-Sánchez
ECEsther Perez Carrillo
Esther Perez Carrillo
Luis Martín Marín-ObispoLuis Martín Marín-Obispo
Luis Martín Marín-Obispo
Daniel Jacobo-VelázquezDaniel Jacobo-Velázquez
Daniel Jacobo-Velázquez
In this study, a milk chocolate formulation was developed to serve as vehicle of Omega-3 (ω3) polyunsaturated fatty acids (PUFAs) and probiotics (L. plantarum 299v and L. rhamnosus GG). Fish oil (FO) was incorporated in chocolate as a source of ω3 PUFAs. Probiotics (Prob) and FO were added during tempering, obtaining chocolates with 76.0 ± 5.2 mg (FO1) or 195.8 ± 6.5 mg (FO2) of ω3 PUFAs, and >1 × 106 CFU of Prob per chocolate portion (12 g). The physicochemical properties (rheological analysis, texture, surface instrumental color, aw, and fatty acid profile), and sensory acceptability of the formulations were determined. Prob and FO generated a decrease in L* and white index (WI) values. Except for Prob + FO2, all treatments showed a decrease in aw. Rheological parameters of FO1 and Prob + FO1 presented the most similar behavior as compared with the control. Prob or FO1 addition did not affect the overall consumer’s acceptability of chocolate; and when both nutraceuticals were combined (Prob + FO1) the product showed adequate overall acceptability. FO2 formulations were not considered adequate to maintain physicochemical properties and sensory acceptability of chocolate. Results indicated that milk chocolate is a suitable vehicle for delivering ω3 PUFAs and Prob, which are essential to enhance cognitive development in children.

28 April 2021 in Journal of Food Science
Verified
Journal Article
Closed access
PDF file
Andrea Gómez-FernándezAndrea Gómez-Fernández
Andrea Gómez-Fernández
YSYolanda Arlette Santacruz
Yolanda Arlette Santacruz
Daniel Jacobo-VelázquezDaniel Jacobo-Velázquez
Daniel Jacobo-Velázquez

13 December 2022 in Foods
Verified
Journal Article
Open access
PDF file
INIris Margarita García Núñez
Iris Margarita García Núñez
YSYolanda Arlette Santacruz
Yolanda Arlette Santacruz
SSSergio Serna Saldivar
Sergio Serna Saldivar
SCSandra Castillo
Sandra Castillo
CACarlos A. Amaya-Guerra
Carlos A. Amaya-Guerra
This research is aimed to search for suitable probiotic plus prebiotic combinations for food applications. Sixteen bacteria were tested for resistance to low pH, bile salts and antibiotics, and their adhesion to Caco-2 cells, in order to select potential probiotics. Then, two bacteria were selected to study short chain fatty acids production in a starch-based soluble corn fiber or inulin media. Lactiplantibacillus plantarum V3 and L. acidophilus La3 manifested the best probiotic features with a remarkable adhesion ability (23.9% and 17.3%, respectively). Structural differences between fibers have an impact on how each one is metabolized, both in their capacity of being easily fermented and in the short chain fatty acids profile obtained: L. acidophilus La3 in inulin fermentation yielded the highest total short chain fatty acids (85.7 mMol/L), and, in starch-based soluble corn fiber fermentation, yielded the highest butyric acid content (0.31 mMol/L). This study provides valuable information for future design of synbiotics for food applications.

12 August 2021 in Foods
Verified
Journal Article
Open access
PDF file
Andrea Gómez-FernándezAndrea Gómez-Fernández
Andrea Gómez-Fernández
PFPaulinna Faccinetto
Paulinna Faccinetto
NONorma E. Orozco-Sánchez
Norma E. Orozco-Sánchez
ECEsther Perez Carrillo
Esther Perez Carrillo
Luis Martín Marín-ObispoLuis Martín Marín-Obispo
Luis Martín Marín-Obispo
Daniel Jacobo-VelázquezDaniel Jacobo-Velázquez
Daniel Jacobo-Velázquez
Chocolate is an adequate matrix to deliver bioactive ingredients. However, it contains high sugar levels, one of the leading causes of chronic degenerative diseases. This work aimed to evaluate the effects of milk chocolate reformulation with alternative sugar sweeteners (Sw; isomalt + stevia), probiotics (Prob), and ω-3 polyunsaturated fatty acids (PUFAs) on its physicochemical properties and consumers’ acceptability. Lactobacillus plantarum 299v (L. p299v) and Lactobacillus acidophilus La3 (DSMZ 17742) were added as Prob strains, and fish oil (FO) was added as the source of ω-3 PUFAs. Prob addition resulted in chocolates with >2 × 107 colony forming unit (CFU) per serving size (12 g). Except for Prob, aw values of all treatments were <0.46. Sw and Sw + Prob presented the nearest values to the control in hardness, whereas Sw without FO increased fracturability. FO, Sw + FO, and Sw + Prob + FO contained 107.4 ± 12.84, 142.9 ± 17.9, and 133.78 ± 8.76 mg of ω-3 PUFAs per chocolate, respectively. Prob + FO increased the resistance of chocolate to shear stress, while Sw + FO showed a similar flow behavior to the control. The consumers’ acceptability of Sw + Prob chocolate was adequate, while Sw + Prob + FO had higher acceptability than Prob + FO. Health benefits of reformulated milk chocolates requires further assessment by in vitro, in vivo and clinical studies.

10 March 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
AVAndrea Vega-Vásconez
Andrea Vega-Vásconez
DCDiana Lucinda Castillo-Patiño
Diana Lucinda Castillo-Patiño
JGJavier Alberto Garza-Cervantes
Javier Alberto Garza-Cervantes
YSYolanda Arlette Santacruz
Yolanda Arlette Santacruz
JMJosé Ruben Morones-Ramírez
José Ruben Morones-Ramírez
Background: Candida albicans is the most clinically significant opportunistic fungal pathogen, and the growing resistance to conventional antifungals, particularly azoles and echinocandins, highlights the urgent need for alternative therapeutic strategies. Although lactic acid bacteria (LAB) have shown inhibitory potential against C. albicans, the relative contributions of live probiotics, heat-inactivated postbiotics, and cell-free supernatants (CFSs) have rarely been compared in parallel under physiologically relevant conditions against a clinical oral isolate. Results: This study systematically evaluated the antifungal activity of Lactiplantibacillus plantarum 299V, Lactobacillus delbrueckii subsp. bulgaricus ATCC 11842, and Lactobacillus acidophilus ATCC 4356 using co-culture assays, minimum inhibitory concentration tests, agar well diffusion assays, and optical microscopy. L. plantarum achieved the strongest inhibitory effect in co-culture, reducing C. albicans viability by 2.39 log10 CFU/mL after 24 h, correlating with the greatest acidification of the culture medium. Methods: CFS from L. acidophilus inhibited fungal growth by 79.01% at native pH, declining to 28.35% upon neutralization to pH 7, confirming that antifungal efficacy is largely pH-dependent and driven by undissociated organic acids. At probiotic concentrations of 1 × 109 CFU/mL, all strains completely suppressed fungal growth. Heat-inactivated postbiotics exhibited up to 95.14% inhibition in MIC assays; however, microscopic analysis revealed coaggregation between postbiotic and fungal cells, which likely interfered with optical density measurements. Conclusions: These findings establish that LAB-mediated antifungal activity is multifactorial and assay-dependent, and highlight the importance of distinguishing between probiotic, postbiotic, and CFS effects when developing LAB-based antifungal strategies.